About the Study
This study is looking at how well the study drug, PRAX-628, works for treating focal seizures compared to placebo, as well as its safety and side effects compared with placebo.
If you qualify and choose to participate, there is a 50% chance you will receive the study drug and a 50% chance you will receive a placebo. A placebo is an inactive material that looks like PRAX-628 but does not contain any active study drug.
You will be on this study for about 23 weeks which will include a screening period, a treatment period, and a follow-up period. You will be required to come into the clinic for up to 3 visits. You will also have 2 home health visits and attend up to 4 remote (over the phone) visits.